Clinical Trial Update: Circulating Cell-free DNA as a Predictive Biomarker for Hepatocelluar Carcinoma.

View source ↗

Summary

This entry reports on a clinical trial evaluating circulating cell-free DNA as a predictive biomarker for hepatocellular carcinoma. The study is registered as N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Hepatocellular Carcinoma | Status: UNKNOWN